Frede Donskov

168 posts

Frede Donskov

Frede Donskov

@FDonskov

Clinical Professor in Oncology, University Hospital of Southern Denmark, Esbjerg, Denmark.

Tham gia Aralık 2019
240 Đang theo dõi238 Người theo dõi
Frede Donskov đã retweet
Milan Hora
Milan Hora@milanhoraplzen·
Cytoreductive nephrectomy associated with longer OS in patients with #mRCC treated with immune checkpoint inhibitor (ICI) therapy in any line of therapy. A multicenter retrospective cohort study of 367 patients (CN+ST 232, ST alone 135). sciencedirect.com/science/articl…
Milan Hora tweet mediaMilan Hora tweet media
Vejprnice, Česká republika 🇨🇿 English
5
44
157
0
Frede Donskov
Frede Donskov@FDonskov·
@KidneyCancer Sad news. Nicholas Vogelzang was a pioneer, a true leader, and a nice person!
English
0
0
2
0
Kidney Cancer
Kidney Cancer@KidneyCancer·
We are sad to announce Dr. Nicholas J. Vogelzang, co-founder of the KCA, died on September 20th. The KCA became a reality around Dr. Vogelzang's kitchen table in 1990 and he remained a dynamic and steadfast supporter of the organization and its mission throughout his life. 1/2
Kidney Cancer tweet media
English
19
38
167
0
Frede Donskov đã retweet
Myriam Chalabi
Myriam Chalabi@MyriamChalabi·
About the smile: the standing ovation also meant that people saw what I knew: behind every one of these bars is a patient. I know every name and have seen almost everyone. I know their stories and their children. And I believe many are cured because of this. #ESMO22 #ChalabiPlot
Myriam Chalabi tweet media
English
34
252
1.9K
0
Frede Donskov đã retweet
Toni Choueiri, MD
Toni Choueiri, MD@DrChoueiri·
A waterfall plot or a tidal wave 🌊???? 🤩 😯 99% pathologic response with nivo/ipi in dMMR CRC and NO disease recurrences!! #ESMO22@myESMO⁩ ⁦@MyriamChalabi
Toni Choueiri, MD tweet media
English
12
125
567
0
Frede Donskov
Frede Donskov@FDonskov·
Important study published. Leibovich and GRANT validated in ccRCC and non-ccRCC nationwide #kidneycancer cohort. Leibovich outperformed GRANT in predicting recurrence-free survival and should remain standard approach to risk stratify patients. @oncoalert doi.org/10.1111/iju.14…
Yüksel Ürün@DrYukselUrun

Do we have a Litmus test to predict survival in localized kidney cancer? 🔸7653 patients: GRade, Age, Nodes, and Tumor score (GRANT) 🇩🇰 🔸Leibovich score outperformed the GRANT regarding RFS @FDonskov @OncoAlert @Uroweb @urotoday @NessnAzawi @KidneyCancer onlinelibrary.wiley.com/doi/10.1111/ij…

English
0
3
10
0